ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,969 | +94.4% | 46,347 | +121.4% | 0.06% | +87.1% |
| Q4 2022 | $2,556 | -97.7% | 20,930 | +1816.7% | 0.03% | +3000.0% |
| Q3 2022 | $113,000 | +1.8% | 1,092 | +15.9% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | +2.8% | 942 | +17.8% | 0.00% | 0.0% |
| Q4 2021 | $108,000 | -79.2% | 800 | -75.4% | 0.00% | -50.0% |
| Q3 2021 | $519,000 | +56.3% | 3,254 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $332,000 | +0.9% | 2,527 | +28.2% | 0.00% | 0.0% |
| Q4 2020 | $329,000 | +82.8% | 1,971 | +68.9% | 0.00% | +100.0% |
| Q3 2020 | $180,000 | -27.7% | 1,167 | -47.3% | 0.00% | -50.0% |
| Q1 2020 | $249,000 | -54.9% | 2,213 | -44.3% | 0.00% | -60.0% |
| Q4 2019 | $552,000 | -43.5% | 3,971 | -60.9% | 0.01% | -37.5% |
| Q3 2019 | $977,000 | -34.9% | 10,146 | -22.1% | 0.01% | -20.0% |
| Q2 2019 | $1,500,000 | +509.8% | 13,027 | +523.9% | 0.01% | +400.0% |
| Q1 2019 | $246,000 | +112.1% | 2,088 | +12.6% | 0.00% | +100.0% |
| Q4 2018 | $116,000 | -84.8% | 1,854 | -83.8% | 0.00% | -85.7% |
| Q2 2018 | $762,000 | – | 11,461 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |